The DPP4 Inhibitor Linagliptin Protects from Experimental Diabetic Retinopathy

• Nadine Dietrich,

  Affiliation 5th Medical Department, Universitätsmedizin Mannheim, University of Heidelberg, Mannheim, Germany

  ⨯
• Matthias Kolibabka,

  Affiliation 5th Medical Department, Universitätsmedizin Mannheim, University of Heidelberg, Mannheim, Germany

  ⨯
• Stephanie Busch,

  Affiliation 5th Medical Department, Universitätsmedizin Mannheim, University of Heidelberg, Mannheim, Germany

  ⨯
• Petra Bugert,

  Affiliation 5th Medical Department, Universitätsmedizin Mannheim, University of Heidelberg, Mannheim, Germany

  ⨯
• Ulrike Kaiser,

  Affiliation 5th Medical Department, Universitätsmedizin Mannheim, University of Heidelberg, Mannheim, Germany

  ⨯
• Jihong Lin,

  Affiliation 5th Medical Department, Universitätsmedizin Mannheim, University of Heidelberg, Mannheim, Germany

  ⨯
• Thomas Fleming,

  Affiliation Department of Medicine I, University of Heidelberg, Heidelberg, Germany

  ⨯
• Michael Morcos,

  Affiliation 5th Medical Department, Universitätsmedizin Mannheim, University of Heidelberg, Mannheim, Germany

  ⨯
• Thomas Klein,

  Affiliation Department of CardioMetabolic Diseases Research, Boehringer Ingelheim Pharma, Biberach, Germany

  ⨯
• Andrea Schlotterer,

  Affiliation 5th Medical Department, Universitätsmedizin Mannheim, University of Heidelberg, Mannheim, Germany

  ⨯
• Hans-Peter Hammes

  * E-mail: hp.hammes@umm.de

  Affiliation 5th Medical Department, Universitätsmedizin Mannheim, University of Heidelberg, Mannheim, Germany

  ⨯